CVR: 26382785
PHARMA 2100 ApS was a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002 and dissolved in 2018. The company was registered under the industry Industriel design og produktdesign. The company has 1 employee. In 2017, the company reported revenue of DKK 0 and a net result of DKK -20,455 compared with DKK 0 the year before. Equity amounted to DKK 29,371.
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringScreen owners and management against the Danish FSA's official PEP lists
PHARMA 2100 ApS was dissolved on October 23, 2018.
As of March 16, 2018, Lotte Lundin has stepped down as liquidator of PHARMA 2100 ApS.
On March 16, 2018, PHARMA 2100 ApS exited liquidation.
As of February 1, 2018, Lotte Lundin is registered as liquidator of PHARMA 2100 ApS.
On February 1, 2018, PHARMA 2100 ApS entered liquidation.
As of December 7, 2017, Niels Meidahl has stepped down as director of PHARMA 2100 ApS.
PHARMA 2100 ApS has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK -20,455.
PHARMA 2100 ApS has published its annual report for 2016. Revenue came to DKK 0, and the net result was DKK 0.
As of April 12, 2017, Niels Meidahl is registered as director of PHARMA 2100 ApS.
As of January 16, 2017, Sven Lange has left the board of directors of PHARMA 2100 ApS.
As of January 16, 2017, Sven Lange has stepped down as adm. dir of PHARMA 2100 ApS.
As of January 16, 2017, Bella da Silva Buxbom has stepped down as chairman of PHARMA 2100 ApS.
PHARMA 2100 ApS has published its annual report for 2015. Gross profit came to DKK -2,166, and the net result was DKK -2,166.
As of December 19, 2014, Bella da Silva Buxbom is registered as chairman of PHARMA 2100 ApS.
As of December 19, 2014, Jens Meidahl has stepped down as chairman of PHARMA 2100 ApS.
PHARMA 2100 ApS has published its annual report for 2014. Revenue came to DKK 0, and the net result was DKK -5,348.
PHARMA 2100 ApS has published its annual report for 2013. Revenue came to DKK 0, and the net result was DKK -25,250.
PHARMA 2100 ApS has published its annual report for 2012. Revenue came to DKK 0, and the net result was DKK -50,000.
As of November 16, 2011, Jens Meidahl is registered as chairman of PHARMA 2100 ApS.
As of November 16, 2011, Niels Meidahl has stepped down as chairman of PHARMA 2100 ApS.
As of November 1, 2010, Sven Lange has joined the board of directors of PHARMA 2100 ApS.
As of November 1, 2010, Ole Bitsch-Jensen has left the board of directors of PHARMA 2100 ApS.
As of November 1, 2010, Niels Meidahl is registered as chairman of PHARMA 2100 ApS.
As of November 1, 2010, Bent Holmegaard has stepped down as chairman of PHARMA 2100 ApS.
As of October 30, 2009, SØLYST TOTALENTREPRISE ApS has stepped down as auditor of PHARMA 2100 ApS.
As of February 7, 2005, Sven Lange is registered as adm. dir of PHARMA 2100 ApS.
As of December 16, 2004, Ole Bitsch-Jensen has joined the board of directors of PHARMA 2100 ApS.
As of December 16, 2004, Bent Holmegaard is registered as chairman of PHARMA 2100 ApS.
As of December 16, 2004, René Spurre has stepped down as direktion of PHARMA 2100 ApS.
As of May 13, 2004, SØLYST TOTALENTREPRISE ApS has been appointed auditor of PHARMA 2100 ApS.
As of June 17, 2002, Henrik Ulvsgaard has stepped down as auditor of PHARMA 2100 ApS.
As of June 17, 2002, René Spurre is registered as direktion of PHARMA 2100 ApS.
As of June 17, 2002, Steen Schierbeck has stepped down as direktion of PHARMA 2100 ApS.
As of January 1, 2002, Henrik Ulvsgaard has been appointed auditor of PHARMA 2100 ApS.
As of January 1, 2002, Steen Schierbeck is registered as direktion of PHARMA 2100 ApS.
PHARMA 2100 ApS was founded on January 1, 2002.
companydata.dk